Palisade Bio share price logo

Palisade Bio

NASDAQ: PALI

$1.34

-0.01

(-0.37%)

Live

as on

Palisade Bio Stock Performance

as on October 24, 2026 at 6:25 am IST

  • Day's Low

    Day's High

    $1.28
    $1.37
    downward going graph

    4.48%

    Downside

    2.24%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.32
    $2.86
    downward going graph

    1.49%

    Downside

    113.06%

    Upside

    downward going graph

Palisade Bio share price movements today

Previous Close
$1.35
Open
$1.33
Volume
1.0M
Market Cap
$244.0M
Day's Low - High
$1.28 - $1.37
52 Week Low - High
$1.32 - $2.86

Palisade Bio Historical Returns

1 Month Return
-15.62 %
3 Month Return
-33.17 %
1 Year Return
-23.73 %
3 Year Return
-84.97 %
5 Year Return
-99.93 %

Palisade Bio Stock Fundamentals & Key Indicators

Check Palisade Bio market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$244.0M

EPS (TTM)

-0.5316

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.63

Industry PE ratio

-3.14

PEG Ratio

-0.01

EBITDA

-33.2M

Revenue (TTM)

500.0K

Profit Margin

100.00%

Return On Equity TTM

-33.47%

Palisade Bio vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Palisade Bio with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$244.0M-99.93%-2.63100.00%0.00%
Neutral$98.1B-37.95%-30.80-12.57%0.00%
StrongBuy$44.0BNA27.4787.82%0.00%
StrongBuy$132.9B191.61%30.2886.04%0.00%
Buy$83.1B43.11%19.2484.86%0.46%

Stock Returns calculator for Palisade Bio Stock including INR - Dollar returns

The Palisade Bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Palisade Bio investment value today

Current value as on today

₹81,882

Returns

-₹18,118

(-18.12%)

Returns from Palisade Bio Stock

-₹24,294 (-24.29%)

Dollar Impact

₹6,176 (+6.18%)

Analyst Recommendation on Palisade Bio Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Palisade Bio. Average target price of $9.8

Palisade Bio Share Price Target

Get share price movements and forecasts by analysts on Palisade Bio.

What analysts predicted

86.33%UPSIDE

Target Price

$9.8

Current Price

$1.34

Analyzed by

3 Analysts

High

$25

Target

$9.80

Low

$7

Palisade Bio target price $9.8, a slight upside of 86.33% compared to current price of $1.34. According to 3 analysts rating.

Indian Investors' Interest in Palisade Bio Stock

Search interest for Palisade Bio Stock has increased by 110% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:110% versus previous 30 day period

Palisade Bio Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
0
Gross Profit
0
-
0
-
-
-
-
-
-
0
Operating Income
-3
-4
-3
-3
-2
-2
-2
-9
-10
-11
EBITDA
-3
-4
-3
-3
-2
-2
-2
-10
-9
-10
Interest Expense
0
0
0
0
0
0
0
0
0
-
Depreciation
0
0
0
-
0
0
0
-
-
-
Income Before Tax
-3
-4
-3
-3
-2
-2
-2
-8
-9
-10
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-3
-4
-3
-3
-2
-2
-2
-8
-9
-10
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
100.00%

Palisade Bio Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
0
-
-
-
0
-
-
Gross Profit
0
1
0
0
-
-
0
-
-
Operating Income
-13
-8
-8
-9
-41
-15
-13
-14
-18
EBITDA
-15
-4
-8
-10
-24
-14
-12
-14
-16
Interest Expense
0
0
0
0
2
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-15
-4
-8
-10
-26
-14
-12
-14
-16
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-15
-4
-8
-10
-26
-14
-12
-14
-16
Net Profit Margin
100.00%
480.77%
100.00%
0.00%
0.00%
0.00%
100.00%
0.00%
0.00%

Palisade Bio Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-3
-4
-3
-3
-2
-2
-2
-8
-9
-10
Operating Cash Flow
-3
-3
-3
-2
-2
-1
-3
-3
-3
-7
Investing Cash Flow
-
-
-
-
-
-
-
-
-
-
Financing Cash Flow
2
3
0
4
0
0
3
131
3
0
Change in Cash
-1
0
-3
1
-2
-1
0
128
0
-7

Palisade Bio Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-15
-4
-8
-10
-26
-14
-12
-14
-16
Operating Cash Flow
-13
-7
-7
-4
-14
-13
-11
-12
-10
Investing Cash Flow
0
4
-
0
0
0
0
-
-
Financing Cash Flow
4
1
6
1
24
15
11
9
134
Change in Cash
-8
0
0
-2
9
1
0
-2
123

Global Institutional Holdings in Palisade Bio

Check out the Institutions with significant holdings in Palisade Bio.

Funds
Holdings
Vanguard
5.16%
Joseph Edelman
4.83%
Peter Kolchinsky
4.09%
iShares
3.58%
Federated Hermes Equity Funds
1.80%

Insights on Palisade Bio

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 671.9% return, outperforming this stock by 695.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 157.7% return, outperforming this stock by 242.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, PALI stock has moved down by -85.0%

About Palisade Bio

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, engages in developing oral phosphodiesterase-4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon in the United States. Its lead clinical product candidate includes PALI-2108, which is in phase 1b clinical trial to treat patients with inflammatory bowel disease, including ulcerative colitis and Fibrostenotic Crohn’s disease. The company has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company was founded in 2001 and is headquartered in Denver, Colorado.
OrganisationPalisade Bio
Headquarters4600 South Syracuse Street, Denver, CA, 80237, US
IndustryBiotechnology
CEOJ. D. Finley

Key Management of Palisade Bio

Name

Title

Mr. J. D. Finley

CEO, CFO & Director

Dr. Mitchell Lawrence Jones M.D., Ph.D.

President & Chief Medical Officer

Dr. Joerg Heyer Ph.D.

Head of Translational Science & Medicine

Mr. Daniel J. Larkins

Head of Global Regulatory Affairs

Mr. Adarsh Patel M.B.A., M.S.

Head of Chemistry, Manufacturing & Controls

FAQs

What is Palisade Bio share price today?

Palisade Bio share price today is $1.34 as on . Palisade Bio share today touched a day high of $1.37 and a low of $1.28.

What is the 52 week high and 52 week low for Palisade Bio share?

Palisade Bio share touched a 52 week high of $2.86 on and a 52 week low of $1.32 on . Palisade Bio stock price today i.e. is trending at $1.34,which is 53.06% down from its 52 week high and 1.52% up from its 52 week low.

What is Palisade Bio's market capitalisation today?

Palisade Bio market capitalisation is $0.00T as on .

How to invest in Palisade Bio Stock (PALI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Palisade Bio on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Palisade Bio Stock (PALI) from India?

Indian investors can start investing in Palisade Bio (PALI) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Palisade Bio stock (as per the Rupee-Dollar exchange rate as on ). Based on Palisade Bio share’s latest price of $1.34 as on October 24, 2026 at 12:55 am IST, you will get 7.4627 shares of Palisade Bio. Learn more about fractional shares .

What are the returns that Palisade Bio has given to Indian investors in the last 5 years?

Palisade Bio stock has given -99.93% share price returns and 26.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?